ALG-010184

N/A

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameALG-010184
Drug Alias NameALG-010184
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionCapsid protein modulators
TargetsCapsid protein
Therapy Area/IndicationsHepatitis B, Chronic
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesAligos Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesAligos Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHepatitis B, Chronic
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A